Izindaba Zenkampani

Ukukhuthaza Impilo Nokululama: Ukunakekelwa Kwansuku Zonke Kweziguli Ze-Leukemia
Ukuqinisekisa ukwelashwa okuphephile nokunethezekile kweziguli ze-leukemia kuhilela ukunakekelwa ngokucophelela kwansuku zonke, okuhlanganisa ukukhucululwa kwemvelo, ukuhlanzeka komuntu siqu, ukudla okunomsoco, nokuzivocavoca okufanele. Lo mhlahlandlela unikeza izeluleko ezibalulekile zokunakekelwa kwansuku zonke okusebenzayo ukusekela ukululama.

I-NS7CAR-T Cell Therapy Ibonisa Isithembiso Sokwelapha i-R/R T-ALL/LBL
Ucwaningo lwakamuva lugqamisa ukusebenza kahle nokuphepha kwe-NS7CAR-T cell therapy ekwelapheni i-T-cell acute lymphoblastic leukemia (R/R T-ALL) ebuyele emuva noma eyi-refractory (R/R T-ALL) kanye ne-T-cell lymphoblastic lymphoma (R/R T-LBL). Lokhu kwelashwa kunikeza ithemba elisha ezigulini ezinalezi zinhlobo zomdlavuza ezinolaka.

Simemezela Iforamu Yonyaka Ka-2024 ye-Lu Daopei Hematology ngo-Agasti
I-12th Annual Lu Daopei Hematology Forum izoba ngo-Agasti 23-24, 2024, e-Beijing International Convention Centre. Hlanganyela nathi ukuze uthole izingxoxo ezihlakaniphile kanye nentuthuko yakamuva ku-hematology.

2023 ASH Ukuvulwa | UDkt. Peihua Lu Wethula I-CAR-T Yocwaningo Lwe-AML Olubuyelelwe kabusha /Refractory










